Mountain Valley MD Holdings Inc.

CONCORD, A6 · CIK 0001806862 · Biotech · Public

Proprietary peptide delivery technology and agricultural biotech products

mvmd.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.4M
2 Form D · Jun 2026
3 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$192,948
Private capital raisedForm D · SEC$1,212,955
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2558Biomakers, Inc.—$1.5M
2559Resilience Therapeutics, Inc.—$1.4M
2560MARKER GENE TECHNOLOGIES INC——
2561Mountain Valley MD Holdings Inc.—$1.4M
2562STATEGICS, INC.——
2563Sentia Medical Sciences, Inc.——
2564Island Pharmaceuticals Ltd—$1.2M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Matthew AndersonExecutive Officer
  • David BatchelorDirector
  • Dennis HancockDirector · Executive Officer
  • Paul LockhardDirector
  • Kevin PuloskiDirector
  • Nancy RichardsonDirector
  • Aaron TriplettExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.